JPM vs REGN Stock Comparison
REGN currently leads JPM in this stock comparison, with AIQ scores of 68 vs 52. The clearest difference is momentum, while JPM has the stronger risk resilience profile.
What is the main difference between JPM and REGN?
REGN leads the current stock comparison as Regeneron Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
JPMorgan Chase & Co. vs Regeneron Pharmaceuticals, Inc.
REGN leads
REGN leads by 16 AIQ points, primarily on Momentum and Quality, and the lead has widened from 6 points over 30 sessions. Wall Street currently favors JPM on target upside.
Stable: 4 of 6 evidence groups support REGN, its lead is widening, and its signal state is cleanly positive.
JPMorgan Chase & Co.
Regeneron Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors REGN over JPM, 68 versus 52 as of Oct 21, 2026. REGN's advantage is driven primarily by stronger momentum and quality, while JPM holds the stronger risk resilience profile. REGN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors JPM. 4 of 6 covered evidence groups favor REGN today, and the comparison is rated Stable on stability. REGN lead: Strengthening — the AIQ differential moved from 6 to 16 points over 30 sessions.
Compare JPMorgan Chase & Co. and Regeneron Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare JPM and REGN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum58 vs 91REGN +33
- Quality46 vs 73REGN +27
- Risk Resilience68 vs 60JPM +8
- Value44 vs 48REGN +4
4 of 6 evidence groups favor REGN. REGN’s edge is concentrated in momentum and quality; JPM keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +8
No signal started or stopped since the prior session; its 2 active signals are unchanged.
Largest factor move: Momentum +17
New signals
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
REGN's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — JPM and REGN both carry a full feed there.
The central trade-off
REGN (Regeneron Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum and quality.
JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
REGNREGN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
REGNREGN on combined revenue and EPS growth.
Value
REGNREGN on the peer-relative Value factor, by 4 points.
Momentum
REGNREGN on the Momentum factor, by 33 points.
Lower downside
JPMJPM on Risk Resilience, by 8 points.
Analyst upside
JPMJPM on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors REGN, analyst targets favor JPM. That disagreement is the most useful thing on this page.
| Measure | JPM | REGN | Note |
|---|---|---|---|
| Implied upside to target | +11.3% | +2.7% | JPM has more room |
| Target dispersion | +32.2% | +47% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 20 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor REGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | REGN | 52 vs 68 |
| Fundamentals | REGNon balance | revenue growth -7.6% vs 19%; EPS growth -27.6% vs 80.1%; TTM ROE 17.9% vs 13.8%; gross margin 63.2% vs 84.9%; operating margin 28.2% vs 25.6% — REGN takes 3 of 5 decided legs, not all of them |
| Valuation | REGN | Value 44 vs 48 |
| Technicals | REGN | Price vs 50-day -3.4% vs 1.9%; vs 200-day 4% vs 9.8% |
| Risk Resilience | JPM | Risk Resilience 68 vs 60 |
| Analyst expectations | JPM | Target upside 11.3% vs 2.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and REGN and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 16 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on REGN.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20REGN lead: Strengthening — the AIQ differential moved from 6 to 16 points over 30 sessions.
- Today
- REGN +16
- 52 vs 68
- 7 sessions ago
- REGN +18
- 47 vs 65
- 30 sessions ago
- REGN +6
- 43 vs 49
- 90 sessions ago
- REGN +15
- 53 vs 68
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish
No signal that the other name lacks.
4 bullish / 0 bearish
Only REGN
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, MACD Bullish Crossover.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.02%, AIQ +3 points).
Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -0.22%, AIQ +4 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM closes the Momentum gap — currently 33 points behind, the largest single contributor to REGN's edge.
- 2JPM generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish or Uptrend Structure Active.
- 3REGN's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
REGN leads on balance| Metric | JPM | REGN |
|---|---|---|
| Revenue growth (YoY) | -7.6% | 19% |
| EPS growth (YoY) | -27.6% | 80.1% |
| Gross margin | 63.2% | 84.9% |
| Operating margin | 28.2% | 25.6% |
| Return on equity (TTM) | 17.9% | 13.8% |
| Debt to equity | 3.32 | 0.06 |
Performance
REGN leads 6 of 6 windows| Metric | JPM | REGN |
|---|---|---|
| 1 week (5 sessions) | 1.2% | 7.2% |
| 1 month (20 sessions) | -1.4% | 0.4% |
| 3 months (63 sessions) | -3.7% | 24% |
| 6 months (126 sessions) | 7.1% | 8% |
| Year to date | 4% | 4.6% |
| 1 year (252 sessions) | 12.3% | 41.9% |
Technicals
REGN has the stronger structure| Metric | JPM | REGN |
|---|---|---|
| RSI (14) | 57.4 | 64.8 |
| ADX (14) | 20.5 | 18.8 |
| Price vs 50-day | -3.4% | 1.9% |
| Price vs 200-day | 4% | 9.8% |
| Volatility (1M, annualized) | 14.8% | 31.2% |
Risk
JPM is the more resilient| Metric | JPM | REGN |
|---|---|---|
| Beta | 0.75 | 0.58 |
| Sharpe ratio | 0.47 | 1.05 |
| Sortino ratio | 0.66 | 1.7 |
| Max drawdown | -15.5% | -26.1% |
| Current drawdown | -8.2% | -5.2% |
| Annualized volatility | 22.2% | 33.5% |
| Value at risk (95%) | -2.4% | -2.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, JPM or REGN?
On the Algovestiq AIQ Score, REGN is the stronger of the two as of Oct 21, 2026, scoring 68 against JPM's 52. The edge comes from momentum and quality. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is JPM or REGN the better buy right now?
REGN carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor REGN over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. REGN leads Momentum by 33 points; REGN leads Quality by 27 points; JPM leads Risk Resilience by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, JPM or REGN?
Analyst price targets imply +11.3% upside for JPM and +2.7% for REGN, so the Street currently favors JPM. That points the opposite way to the AIQ Score, which favors REGN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, JPM or REGN?
REGN is the better-valued of the two on the peer-relative Value factor. REGN on the peer-relative Value factor, by 4 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, JPM or REGN?
REGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, JPM or REGN?
REGN on the Momentum factor, by 33 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, JPM or REGN?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is JPM more profitable than REGN?
The profitability evidence is mixed: gross margin 63.2% vs 84.9%; operating margin 28.2% vs 25.6%; ttm roe 17.9% vs 13.8%. JPM leads on two measures and REGN on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is REGN's lead over JPM getting stronger or weaker?
REGN lead: Strengthening — the AIQ differential moved from 6 to 16 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.
What would change the JPM vs REGN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Momentum gap — currently 33 points behind, the largest single contributor to REGN's edge; JPM generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish or Uptrend Structure Active; REGN's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about JPM and REGN?
JPM: 2 bullish / 0 bearish. REGN: 4 bullish / 0 bearish. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On REGN it is Golden Cross Active (bullish, long horizon).
Compare JPM and REGN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.